|
BR112019009495A2
|
|
methods of treating inflammatory disorders with multivalent fc compounds
|
|
KR20190095929A
|
|
Optimization of the Manufacturing of the Multimerized Stramer GL-2045
|
|
CA3029744A1
|
|
Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced fc receptor binding
|
|
WO2017214321A1
|
|
Cysteine-optimized stradomers
|
|
CA2991254A1
|
|
Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced complement binding
|
|
US2018282424A1
|
|
Molecules with bimodal activity depleting target at low dose and increasing immunosuppression at higher dose
|
|
AU2015200330A1
|
|
Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions
|
|
AU2013263716A1
|
|
Immunoglobulin constant region FC receptor binding agents
|
|
AU2013305885A1
|
|
Molecules with antigen binding and polyvalent Fc gamma receptor binding activity
|
|
CA2899433A1
|
|
Fusion proteins comprising igg2 hinge domains
|
|
KR20180050429A
|
|
Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions
|
|
EP2430153A1
|
|
Methods of using immunoglobulin aggregates
|
